Detalles de la búsqueda
1.
Osimertinib in combination with anti-angiogenesis therapy presents a promising option for osimertinib-resistant non-small cell lung cancer.
BMC Med
; 22(1): 174, 2024 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38658988
2.
Exosomes transmit T790M mutation-induced resistance in EGFR-mutant NSCLC by activating PI3K/AKT signalling pathway.
J Cell Mol Med
; 24(2): 1529-1540, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31894895
3.
EGFR-targeted therapy alters the tumor microenvironment in EGFR-driven lung tumors: Implications for combination therapies.
Int J Cancer
; 145(5): 1432-1444, 2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30784054
4.
Clinical features of Bim deletion polymorphism and its relation with crizotinib primary resistance in Chinese patients with ALK/ROS1 fusion-positive non-small cell lung cancer.
Cancer
; 123(15): 2927-2935, 2017 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28346673
5.
Uncommon EGFR mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinum-based chemotherapy.
Chin J Cancer Res
; 29(6): 543-552, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29353977
6.
The Effect of Topical Vancomycin Powder Application on the Rate of Intervertebral Fusion Following Lumbar Fusion: A Retrospective Study.
World Neurosurg
; 185: e1216-e1223, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38514028
7.
Tumour microenvironment changes after osimertinib treatment resistance in non-small cell lung cancer.
Eur J Cancer
; 189: 112919, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37320935
8.
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring BRAF mutations.
Transl Lung Cancer Res
; 12(2): 219-229, 2023 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36895926
9.
Single-Cell Profiling of Tumor-Associated Neutrophils in Advanced Non-Small Cell Lung Cancer.
Lung Cancer (Auckl)
; 14: 85-99, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38025400
10.
Primary nephrotic syndrome complicated by chylothorax: a case report.
Ann Palliat Med
; 11(7): 2523-2528, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34775776
11.
Computational recognition of LncRNA signatures in tumor-associated neutrophils could have implications for immunotherapy and prognostic outcome of non-small cell lung cancer.
Front Genet
; 13: 1002699, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36386809
12.
The safety and efficacy of immunotherapy with anti-programmed cell death 1 monoclonal antibody for lung cancer complicated with Mycobacterium tuberculosis infection.
Transl Lung Cancer Res
; 10(10): 3929-3942, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34858782
13.
Concurrent use of metformin enhances the efficacy of EGFR-TKIs in patients with advanced EGFR-mutant non-small cell lung cancer-an option for overcoming EGFR-TKI resistance.
Transl Lung Cancer Res
; 10(3): 1277-1291, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33889509
14.
The Association Between Imaging Features of TSCT and the Expression of PD-L1 in Patients With Surgical Resection of Lung Adenocarcinoma.
Clin Lung Cancer
; 20(2): e195-e207, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30514666
15.
Loss of T790M mutation is associated with early progression to osimertinib in Chinese patients with advanced NSCLC who are harboring EGFR T790M.
Lung Cancer
; 128: 33-39, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30642450
16.
High feasibility of cytological specimens for detection of ROS1 fusion by reverse transcriptase PCR in Chinese patients with advanced non-small-cell lung cancer.
Onco Targets Ther
; 12: 3305-3311, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31118681
17.
Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinoma.
J Hematol Oncol
; 12(1): 75, 2019 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31299995
18.
Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer.
Cancer Immunol Res
; 7(4): 630-643, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30755403
19.
Impact of serum vascular endothelial growth factor and interleukin-6 on treatment response to epidermal growth factor receptor tyrosine kinase inhibitors in patients with non-small-cell lung cancer.
Lung Cancer
; 125: 22-28, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30429024
20.
Prognostic value of PD-L1 expression in combination with CD8+ TILs density in patients with surgically resected non-small cell lung cancer.
Cancer Med
; 7(1): 32-45, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29168339